Constellation EZH2 inhibitor

long-residence time EZH2 inhibitor

oral efficacy in xenograft model

from optimatization of prior EZH2 inhibitor

"ACS Med. Chem. Lett., Mar. 26, 2020

Constellation Pharma., Cambridge, MA

Constellation EZH2 inhibitor (Constellation oral in vivo long-residence time EZH2 inhibitor)


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks